Aldeyra up after resubmitting application for eye disease drug

Aldeyra Therapeutics

03/10/2024 13:42

** Shares of Aldeyra Therapeutics  ALDX.O  rise 1.9% to
$5.40 premarket
    ** Co says it has resubmitted its application for approval
to the U.S. FDA for its dry eye disease drug
    ** Last year, the FDA declined to approve the drug
reproxalap 
    ** Up to last close, stock up 51% YTD

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))